Jacobson Mark L.insider trades
In SEC Form 4 filings, Jacobson Mark L. is listed as Chief Operating Officer of Axsome Therapeutics, Inc. (AXSM). In the last 90 days, Jacobson Mark L. sold $2.09M of Axsome Therapeutics, Inc. (AXSM) on the open market and bought none. The sale was reported under a 10b5-1 trading plan.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| AXSMAxsome Therapeutics, Inc. | Chief Operating Officer | 3 | Sep 3 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-09-03
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| AXSMAxsome Therapeutics, Inc. | Sep 3 | Sep 3 | M | 10,000 | $12.95 | $129,500 | 10,000 | Yes | Form 4 |
| AXSMAxsome Therapeutics, Inc. | Sep 3 | Sep 3 | S | 10,000 | $208.65 | Sale −$2,086,500 | not reported | Yes | Form 4 |
| AXSMAxsome Therapeutics, Inc. | Sep 3 | Sep 3 | M · derivative | 10,000 | $12.95 | $129,500 | 104,954 | Yes | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.